Accrin_ticker_arrow
Current Announcements
Protocol Preactivation Announcement: Alliance A011104/ACRIN 6694
Site recruitment is now underway for the clinical trial “Effect of Preoperative Breast MRI on Surgical Outcomes, Costs, and Quality of Life of Women with Breast Cancer."  read more ...

Results of the NLST Incidence Screens Reported

Detailed findings about the second and third screening examinations from the NLST were reported in the New England Journal of Medicine.

 read more ...

Slideshow image
Accrin_Container_Arrow NCI CENTERS FOR QUANTITATIVE
IMAGING EXCELLENCE
The imaging core laboratory is carrying out the qualification program for this NCI initiative.  More information is available on the ACRIN Web site at NCI-CQIE Qualification Program
Accrin_Container_Arrow DATA CENTER LOGIN

The data center supports around the clock web-based patient registration.  Data Center Login

Accrin_Container_Arrow ACCRUAL TRACKING REPORT

View the real time patient enrollment status for the ACRIN trials.  Accrual Tracker Report

Accrin_Container_Arrow SITE OPERATIONS TOOL
Use the Operations "Ops" Tool to create reports for forms and calendar management. Site Operations Tool
Accrin_Container_Arrow LINKS

Contact Us

TRIAD Pre-Installation Checklist
A document outlining TRIADTM installation procedures and requirements

ACRIN Publications 
Policy document and submission forms for publication review

ACRIN Biostatistics Center 
A link to the Web site of the Center for Statistical Sciences at Brown University

ACRIN History
A link to a description of major milestones throughout ACRIN's 10 years of conducting imaging research. 

NETWORK CHAIR WELCOME

 ACRIN and cancer imaging research have experienced groundbreaking developments within the last decade. We are grateful to have been instrumental in facilitating clinical research that is making a difference in the lives of cancer patients. Several ACRIN trials are now among the highest profile clinical trials in NCI’s portfolio and a majority of trials involve collaboration with therapy cooperative groups or industries.

Looking to future research plans, ACRIN anticipates developing even more precise quantitative approaches to diagnosis and image-guided therapy. Specific objectives involve surveillance of high-risk populations, administration of targeted therapies, and use of biomarkers to evaluate therapeutic response. The new Experimental Imaging Sciences Committee is charged with exploring new modalities, new uses for established modalities, and new equipment. I personally take great pride in the opportunity afforded me to work with so many talented imagers from across the country.

I invite you to explore our Web site to learn more about:

  • How to participate in ACRIN trials and research activities
  • The diversity of ACRIN’s research and related research strategies
  • ACRIN’s extensive support for conducting multi-center trials.

We look forward to playing an active role in the innovations on the horizon for the cancer imaging research community.

Mitchell Schnall, MD, PhD
Network Chair

 
 

A program of the American College of Radiology, ACRIN is a National Cancer Institute cooperative group and receives additional financial support from contributors to the “ACRIN Fund for Imaging Innovation” and other industry and governmental partners.

                                                
ACRIN is pleased to    acknowledge industry partners who have generously contributed to the ACRIN Fund for Imaging Innovation